DECIDE
Developing and Evaluating Communication strategies to support Informed Decisions and practice based on Evidence
| Coordinatore | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN
Organization address
address: KING'S COLLEGE REGENT WALK contact info |
| Nazionalità Coordinatore | United Kingdom [UK] |
| Totale costo | 3˙788˙498 € |
| EC contributo | 2˙999˙312 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2010-two-stage |
| Funding Scheme | CP-FP |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-01-01 - 2015-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN
Organization address
address: KING'S COLLEGE REGENT WALK contact info |
UK (ABERDEEN) | coordinator | 183˙465.20 |
| 2 |
NASJONALT KUNNSKAPSSENTER FOR HELSETJENESTEN
Organization address
address: ST OLAVSPLASS 2 contact info |
NO (OSLO) | participant | 594˙390.50 |
| 3 |
UNIVERSITY OF DUNDEE
Organization address
address: Nethergate contact info |
UK (DUNDEE) | participant | 384˙840.53 |
| 4 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam
Organization address
address: MEIBERGDREEF 9 contact info |
NL (AMSTERDAM) | participant | 327˙346.38 |
| 5 |
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU
Organization address
address: CALLE SANT ANTONI M CLARET 167 contact info |
ES (BARCELONA) | participant | 248˙779.00 |
| 6 |
WORLD HEALTH ORGANIZATION.
Organization address
address: Avenue Appia 20 contact info |
CH (GENEVE) | participant | 238˙692.05 |
| 7 |
UNIVERSITAETSKLINIKUM FREIBURG
Organization address
address: HUGSTETTER STRASSE 49 contact info |
DE (FREIBURG) | participant | 238˙228.00 |
| 8 |
AZIENDA SANITARIA LOCALE ROMA
Organization address
address: Borgo Santo Spirito 3 contact info |
IT (ROMA) | participant | 232˙285.70 |
| 9 |
HEALTHCARE IMPROVEMENT SCOTLAND
Organization address
address: SOUTH GYLE CRESCENT 1 contact info |
UK (EDINBURGH) | participant | 225˙317.92 |
| 10 |
KUSTANNUS OY DUODECIM
Organization address
address: Kalevankatu 20 contact info |
FI (Helsinki) | participant | 121˙871.22 |
| 11 |
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
Organization address
address: "MidCity Place, High Holborn 71" contact info |
UK (LONDON) | participant | 115˙550.50 |
| 12 |
Associazione per la Ricerca sulla Efficacia della Assistenza Sanitaria Centro Cochrane Italiano
Organization address
address: Via Fra Cristoforo 14/D contact info |
IT (Milano) | participant | 88˙545.10 |
| 13 |
NHS QUALITY IMPROVEMENT SCOTLAND
Organization address
address: HILLSIDE CRESCENT - ELLIOTT HOUSE 8-10 contact info |
UK (EDINBURGH) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Objective: To improve the dissemination of evidence-based recommendations by building on the work of the GRADE Working Group to develop and evaluate methods that address the targeted dissemination of guidelines.
Background: Healthcare decision makers face challenges in understanding guidelines, including the quality of the evidence upon which recommendations are made, which often is not clear. Guidelines are also typically developed as a one-size-fits-all package. By developing and evaluating targeted dissemination strategies, DECIDE aims to increase the use of evidence-based interventions in a sustainable way and to reduce the use of interventions where benefits are uncertain.
Methods: GRADE is a systematic approach towards assessing and communicating the quality of evidence and the strength of recommendations. It has been developed to address the weaknesses of other grading systems and is now widely used internationally. The DECIDE consortium, which is composed of members of the GRADE Working Group, will further develop this approach to ensure effective dissemination of evidence-based recommendations targeted at the key stakeholders (healthcare professionals; policymakers and managers; patients and the general public) who determine what happens in clinical practice. We will collect stakeholder input from advisory groups, consultations and user testing. This will be done across a wide range of health systems in Europe. The targeted dissemination strategies that are developed will be evaluated in randomized trials, refined and used and evaluated with real guidelines developed by the DECIDE partners and other guideline developers that we support.
Expected results: Dissemination strategies for recommendations that have been rigorously evaluated in diverse settings, support the transfer of research into practice, and are adapted to real-world healthcare systems.'